Aspire Rural Health System is proud to announce that Deckerville Community Hospital now offers a new, advanced way to detect heart disease—without surgery.
The Heartflow FFRCT Analysis is a non-invasive test that helps doctors better understand how well blood is flowing to the heart. Using a standard CT scan, the test creates a detailed, color-coded 3D image of a patient’s heart. This allows providers to see blockages and determine how serious they are—helping guide the best treatment plan.
Aspire Deckerville is the only provider in the Thumb and one of just three locations in Michigan offering this advanced plaque analysis technology.
Heart disease remains the leading cause of death in the United States and is often called the “silent killer” because many people don’t recognize the symptoms. It occurs when buildup in the arteries reduces blood flow to the heart, which can lead to chest pain, heart attacks, or other serious complications.
Traditional testing doesn’t always give a clear answer and can sometimes lead to unnecessary procedures or missed diagnoses. This new technology helps reduce that uncertainty by giving doctors a more accurate and complete picture of what’s happening inside the heart.
“Heartflow’s technology is a major step forward in how we diagnose and manage heart disease,” said Mike Lewiski, Director of Diagnostic Imaging at Aspire. “It gives providers clearer information so they can make more confident decisions about a patient’s care—all without invasive procedures.”
How it works:
- A patient receives a standard CT scan of the heart
- Advanced technology creates a personalized 3D model
- Doctors can see blockages and how they affect blood flow
Benefits include:
- More accurate, non-invasive diagnosis
- Fewer unnecessary tests and procedures
- Better guidance for personalized treatment
The test may be ordered by a primary care provider, specialist, or cardiologist.
To learn more about Heartflow FFRCT Analysis at Aspire Deckerville, visit www.aspirerhs.org or call 810-376-2835.